The researchers demonstrate the development of a novel Prodosome technology-derived PL425 PEC phytonutrient-enriched electrolyte formulation and its significant contribution in fluid homeostasis as well as enhanced ne...The researchers demonstrate the development of a novel Prodosome technology-derived PL425 PEC phytonutrient-enriched electrolyte formulation and its significant contribution in fluid homeostasis as well as enhanced neuromuscular function, cardio-protection, pulmonary, and other physiological cellular and organ functions. Electrolytes enriched in phytonutrients including polyphenolic bioflavonoids, anthocyanins, saccharides, sulforaphanes, carotenoids and exotic spices, in conjunction with a full spectrum of sea water-derived electrolytes, such as sodium, chloride, potassium, calcium, phosphate, magnesium and bicarbonate, along with vitamin C, all of which are encapsulated in the proprietary Prodosome technology enabling enhanced bioavailability. This technology will maintain important biological functions including metabolic and energy homeostasis, pH equilibration, free radical inhibition, cell-to-cell communication, muscular integrity, enhanced neuronal, cardiovascular, pulmonary, and kidney functions. Moreover, these phytonutrients and electrolytes enhance energy metabolism, ATP production, and activate nitric oxide production without L-Arginine. Ongoing research studies are in progress.展开更多
We hypothesize that Iron-Deficiency Anemia(IDA)has been misconceptualized.In the body,low blood iron is not caused by a deficiency.The primary cause of low iron,appearing to be IDA,is the expenditure of alkalinizing h...We hypothesize that Iron-Deficiency Anemia(IDA)has been misconceptualized.In the body,low blood iron is not caused by a deficiency.The primary cause of low iron,appearing to be IDA,is the expenditure of alkalinizing histidine,from heme protein,which requires the cleavage of iron and its repartitioning to other storage depots.As an alkaline buffer,histidine is released to counterbalance the increase in an anaerobic hypoxic(i.e.increased acidic)blood pH,thereby maintaining a pH of 7.4.Our research team coined the more accurate term for this pathogenic condition,“Chronic Anemia Syndrome”(CAS).展开更多
文摘The researchers demonstrate the development of a novel Prodosome technology-derived PL425 PEC phytonutrient-enriched electrolyte formulation and its significant contribution in fluid homeostasis as well as enhanced neuromuscular function, cardio-protection, pulmonary, and other physiological cellular and organ functions. Electrolytes enriched in phytonutrients including polyphenolic bioflavonoids, anthocyanins, saccharides, sulforaphanes, carotenoids and exotic spices, in conjunction with a full spectrum of sea water-derived electrolytes, such as sodium, chloride, potassium, calcium, phosphate, magnesium and bicarbonate, along with vitamin C, all of which are encapsulated in the proprietary Prodosome technology enabling enhanced bioavailability. This technology will maintain important biological functions including metabolic and energy homeostasis, pH equilibration, free radical inhibition, cell-to-cell communication, muscular integrity, enhanced neuronal, cardiovascular, pulmonary, and kidney functions. Moreover, these phytonutrients and electrolytes enhance energy metabolism, ATP production, and activate nitric oxide production without L-Arginine. Ongoing research studies are in progress.
基金Received:9 November 2020 Accepted:12 November 2020。
文摘We hypothesize that Iron-Deficiency Anemia(IDA)has been misconceptualized.In the body,low blood iron is not caused by a deficiency.The primary cause of low iron,appearing to be IDA,is the expenditure of alkalinizing histidine,from heme protein,which requires the cleavage of iron and its repartitioning to other storage depots.As an alkaline buffer,histidine is released to counterbalance the increase in an anaerobic hypoxic(i.e.increased acidic)blood pH,thereby maintaining a pH of 7.4.Our research team coined the more accurate term for this pathogenic condition,“Chronic Anemia Syndrome”(CAS).
